Thrivent Financial for Lutherans’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.71M | Buy |
26,495
+14
| +0.1% | +$987 | ﹤0.01% | 1564 |
|
|
2025
Q4 | $1.78M | Sell |
26,481
-67,074
| -72% | -$4.51M | ﹤0.01% | 1560 |
|
|
2025
Q3 | $6.86M | Buy |
93,555
+64,542
| +222% | +$4.29M | 0.01% | 746 |
|
|
2025
Q2 | $1.51M | Sell |
29,013
-10,087
| -26% | -$574K | ﹤0.01% | 1539 |
|
|
2025
Q1 | $2.5M | Sell |
39,100
-106
| -0.3% | -$6.16K | 0.01% | 1139 |
|
|
2024
Q4 | $1.87M | Sell |
39,206
-193,810
| -83% | -$9.94M | ﹤0.01% | 1480 |
|
|
2024
Q3 | $13.3M | Sell |
233,016
-709,813
| -75% | -$40.7M | 0.03% | 592 |
|
|
2024
Q2 | $49.4M | Sell |
942,829
-772,015
| -45% | -$33.9M | 0.1% | 261 |
|
|
2024
Q1 | $69.8M | Sell |
1,714,844
-206,815
| -11% | -$7.75M | 0.14% | 198 |
|
|
2023
Q4 | $71M | Sell |
1,921,659
-92,574
| -5% | -$3.49M | 0.15% | 188 |
|
|
2023
Q3 | $76.9M | Sell |
2,014,233
-64,605
| -3% | -$2.65M | 0.18% | 149 |
|
|
2023
Q2 | $75M | Buy |
2,078,838
+1,002,122
| +93% | +$34.2M | 0.17% | 173 |
|
|
2023
Q1 | $41.1M | Buy |
1,076,716
+157,080
| +17% | +$7.37M | 0.1% | 262 |
|
|
2022
Q4 | $52.3M | Sell |
919,636
-398,096
| -30% | -$20.4M | 0.14% | 208 |
|
|
2022
Q3 | $52.1M | Sell |
1,317,732
-8,326
| -0.6% | -$368K | 0.14% | 197 |
|
|
2022
Q2 | $58.3M | Sell |
1,326,058
-140,910
| -10% | -$6.09M | 0.16% | 180 |
|
|
2022
Q1 | $58.5M | Buy |
1,466,968
+390,135
| +36% | +$13.9M | 0.11% | 217 |
|
|
2021
Q4 | $43.3M | Buy |
1,076,833
+323,585
| +43% | +$12.1M | 0.08% | 277 |
|
|
2021
Q3 | $30.6M | Sell |
753,248
-14,460
| -2% | -$605K | 0.06% | 346 |
|
|
2021
Q2 | $34.9M | Buy |
767,708
+33,732
| +5% | +$1.49M | 0.07% | 313 |
|
|
2021
Q1 | $30.6M | Sell |
733,976
-512,639
| -41% | -$23.4M | 0.07% | 334 |
|
|
2020
Q4 | $53.2M | Buy |
1,246,615
+56,814
| +5% | +$2.04M | 0.12% | 214 |
|
|
2020
Q3 | $31.3M | Buy |
1,189,801
+10,423
| +0.9% | +$290K | 0.08% | 288 |
|
|
2020
Q2 | $31.6M | Buy |
1,179,378
+5,170
| +0.4% | +$117K | 0.09% | 262 |
|
|
2020
Q1 | $21.1M | Sell |
1,174,208
-3,232
| -0.3% | -$61.3K | 0.08% | 307 |
|
|
2019
Q4 | $20.9M | Sell |
1,177,440
-2,688,279
| -70% | -$46.6M | 0.06% | 368 |
|
|
2019
Q3 | $60M | Buy |
3,865,719
+80,054
| +2% | +$1.32M | 0.19% | 141 |
|
|
2019
Q2 | $65M | Buy |
3,785,665
+115,835
| +3% | +$1.87M | 0.2% | 133 |
|
|
2019
Q1 | $59.1M | Buy |
3,669,830
+107,325
| +3% | +$1.74M | 0.19% | 152 |
|
|
2018
Q4 | $52.1M | Buy |
3,562,505
+426,775
| +14% | +$6.81M | 0.19% | 135 |
|
|
2018
Q3 | $57M | Buy |
3,135,730
+819,593
| +35% | +$14.4M | 0.18% | 145 |
|
|
2018
Q2 | $39.1M | Buy |
+2,316,137
| New | +$43.8M | 0.13% | 166 |
|
Other funds holding HALO
VCM
VPM
Thrivent Financial for Lutherans's HALO Position: Q1 2026 in Review
Thrivent Financial for Lutherans increased its Halozyme (HALO) stake by 0.05% in Q1 2026, buying an estimated $987 and bringing the position to 26,495 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1564.
Thrivent Financial for Lutherans first reported a position in HALO in Q2 2018 and has held it in 32 quarters since. The position peaked at $76.9M in Q3 2023. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Thrivent Financial for Lutherans held 26,495 shares of Halozyme worth $1.71M as of Q1 2026.
- Thrivent Financial for Lutherans bought 14 Halozyme shares in Q1 2026, an estimated $987.
- Halozyme made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1564 holding.
- Thrivent Financial for Lutherans first reported a position in Halozyme in Q2 2018 and has held it in 32 quarters since.
- Thrivent Financial for Lutherans's Halozyme position peaked at $76.9M in Q3 2023.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.